Discovery of phthalazino[1,2-b]-quinazolinone derivatives as multi-target HDAC inhibitors for the treatment of hepatocellular carcinoma via activating the p53 signal pathway

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves et al. · Science · 2004 · 4.6K citations

Tumor Biology, Small-molecule Antagonists, Mdm2-p53 Interaction +14

FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma

Bhupinder Mann, John R. Johnson, Martin H. Cohen et al. · The Oncologist · 2007 · 1.3K citations · Full text

Non-Cell-Autonomous Tumor Suppression by p53

Amaia Lujambio, Leila Akkari, Janelle Simon et al. · Cell · 2013 · 730 citations · Full text

Non-cell-autonomous Tumor Suppression, Malignant Disease, Tumor Suppressor +4

Histone deacetylase 6 structure and molecular basis of catalysis and inhibition

Yang Hai, David W. Christianson · Nature Chemical Biology · 2016 · 471 citations · Full text

Histone Modifications, Chromatin, Biochemistry +9

Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma

Yue Shi, Mei Dong, Xiaoting Hong et al. · Annals of Oncology · 2015 · 384 citations

Lymphoid Neoplasia, Medicine, Immunology +7